A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs

Martine Bagot, Baktiar Hasan, Sean Whittaker, Marie Beylot-Barry, Robert Knobler, Emad Shah, Sandrine Marreaud, Stephen Morris, Stephane Dalle, Octavio Servitje, Richard Cowan, Liisa Vakeva, Guillaume Chaby, Constanze Jonak, Christopher P. Fox, Diana Ritchie, Maarten H. Vermeer, Rudolf Stadler, Pablo L. Ortiz Romero, Julia ScarisbrickPietro Quaglino, EORTC Cutaneous T- Cell Lymp

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEuropean Journal of Dermatology
Volume27
Issue number3
Pages (from-to)286-294
Number of pages9
ISSN1167-1122
DOIs
Publication statusPublished - May 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • cutaneous T-cell lymphoma
  • maintenance treatment
  • randomized trial
  • lenalinomide
  • anti-angiogenic
  • MYCOSIS FUNGOIDES/SEZARY-SYNDROME
  • SEZARY-SYNDROME
  • INTERNATIONAL-SOCIETY
  • TASK-FORCE
  • CLASSIFICATION
  • ORGANIZATION
  • SURVIVAL
  • PROPOSAL
  • OUTCOMES
  • DISEASE
  • 3121 Internal medicine

Cite this